symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
FBRX,0.559,1.454615,83934,20281526,0,0.5312-1.29,-0.021,"Forte Biosciences, Inc.",USD,0001419041,US34962G1094,34962G109,NASDAQ Capital Market,NASDAQ,Biotechnology,https://www.fortebiorx.com,"Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.",Dr. Paul A.  Wagner Ph.D.,Healthcare,US,7,310 618 6994,3060 Pegasus Park Drive,Dallas,TX,75247,,0,https://financialmodelingprep.com/image-stock/FBRX.png,2017-04-13,False,False,True,False,False
